CARY SKINNER: Open Payments
NPI 1942653621 · NEWBURYPORT, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$488 in 20 payments from 7 companies in 2025. Trend: 2023 $517 · 2024 $490 · 2025 $488
Food & beverage: $488
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $210 |
| Novartis Pharmaceuticals Corporation | 6 | $116 |
| Philips North America LLC | 1 | $41 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Amgen Inc. | 2 | $33 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| Novo Nordisk Inc | 1 | $22 |
Products named: WAINUA, LEQVIO, FARXIGA, Extended Holter, CAMZYOS, REPATHA, JARDIANCE, Ozempic.
Industry payments across MA — which companies pay providers there.
